Esaote Biomedica India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2019)
- Profit 40.46%
(FY 2019)
- Ebitda 40.52%
(FY 2019)
- Net Worth -6.84%
(FY 2019)
- Total Assets -0.55%
(FY 2019)
About Esaote Biomedica India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohanlal Kizhepat, Murali Guturi, and Sukumar Venkutusamy serve as directors at the Company.
- CIN/LLPIN
U33100MH1997PTC105770
- Company No.
105770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 1997
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Esaote Biomedica India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohanlal Kizhepat  | Managing Director | 11-Feb-1997 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sukumar Venkutusamy | Director | 11-Feb-1997 | Current |
| Murali Guturi | Director | 11-Feb-1997 | Current |
Financial Performance and Corporate Structure Insights of Esaote Biomedica India.
Esaote Biomedica India Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 40.46% increase in profit. The company's net worth dipped by a decrease of 6.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Esaote Biomedica India?
In 2019, Esaote Biomedica India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gemini Medical Networks Private LimitedActive 20 years 3 monthsMohanlal Kizhepat, Murali Guturi and 1 more are mutual person
.webp)
Esaote India (Ns) LimitedActive 24 years 6 monthsMohanlal Kizhepat, Murali Guturi and 1 more are mutual person
.webp)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Esaote Biomedica India?
Unlock and access historical data on people associated with Esaote Biomedica India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Esaote Biomedica India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esaote Biomedica India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
